A possible placental factor for preeclampsia: sFlt-1

被引：21

作者：

Kita, Naoko ^{[1
]}

Mitsushita, Junji ^{[2
]}

机构：

[1] Shinshu Univ, Sch Med, Dept Obstet & Gynecol, Nagano 3908621, Japan

[2] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA

来源：

CURRENT MEDICINAL CHEMISTRY | 2008年 / 15卷 / 07期

关键词：

preeclampsia; sFlt-1; PlGF; VEGF; hypoxia;

D O I：

10.2174/092986708783885309

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite its clinical importance, the mechanism of preeclampsia is unclear; however, many believe placental pathology might be related to maternal systemic disease. If this is true, a factor which mediates information from the placenta to the maternal circulation can be hypothesized. Among a variety of such reported factors, soluble fms-like tyrosine kinase-1 (sFlt1) will be the focus of this review. The hypoxic placenta, which is commonly found in preeclampsia, produces sFlt1; furthermore, animal experiments suggest its overexpression leads to preeclampsia-like symptoms.

引用

页码：711 / 715

页数：5

共 89 条

[71] The HELLP-syndrome; maternal-fetal outcome and follow up of infants [J].

Roelofsen, AC ;

van Pampus, MG ;

Aarnoudse, JG .

JOURNAL OF PERINATAL MEDICINE, 2003, 31 (03) :201-208

[72]

Sawano A, 1996, CELL GROWTH DIFFER, V7, P213

[73] FAILURE OF BLOOD-ISLAND FORMATION AND VASCULOGENESIS IN FLK-1-DEFICIENT MICE [J].

SHALABY, F ;

ROSSANT, J ;

YAMAGUCHI, TP ;

GERTSENSTEIN, M ;

WU, XF ;

BREITMAN, ML ;

SCHUH, AC .

NATURE, 1995, 376 (6535) :62-66

[74] Structure and function of VEGF/VEGF-receptor system involved in angiogenesis [J].

Shibuya, M .

CELL STRUCTURE AND FUNCTION, 2001, 26 (01) :25-35

[75] RISK-FACTORS FOR PREECLAMPSIA IN HEALTHY NULLIPAROUS WOMEN - A PROSPECTIVE MULTICENTER STUDY [J].

SIBAI, BM ;

GORDON, T ;

THOM, E ;

CARITIS, SN ;

KLEBANOFF, M ;

MCNELLIS, D ;

PAUL, RH ;

GODFREY, S ;

ROSEN, M ;

CHAO, R ;

GREEN, JD ;

WITTER, F ;

ROCCO, L ;

JEFFERSON, T ;

DEPP, R ;

TANNENBAUM, S ;

CEFALO, RC ;

COTRONEO, M ;

WALLA, C ;

MERCER, BM ;

BRAY, E ;

ROMERO, R ;

HOBBINS, JC ;

SABO, G ;

YAFFE, S ;

CATZ, C .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (02) :642-648

[76] AGGRESSIVE VERSUS EXPECTANT MANAGEMENT OF SEVERE PREECLAMPSIA AT 28 TO 32 WEEKS GESTATION - A RANDOMIZED CONTROLLED TRIAL [J].

SIBAI, BM ;

MERCER, BM ;

SCHIFF, E ;

FRIEDMAN, SA .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (03) :818-822

[77] Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies [J].

Taylor, RN ;

Grimwood, J ;

Taylor, RS ;

McMaster, MT ;

Fisher, SJ ;

North, RA .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (01) :177-182

[78] First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia [J].

Thadhani, R ;

Mutter, WP ;

Wolf, M ;

Levine, RJ ;

Taylor, RN ;

Sukhatme, VP ;

Ecker, J ;

Karumanchi, SA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :770-775

[79] Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia [J].

Tidwell, SC ;

Ho, HN ;

Chiu, WH ;

Torry, RJ ;

Torry, DS .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (06) :1267-1272

[80] Preeclampsia is associated with reduced serum levels of placenta growth factor [J].

Torry, DS ;

Wang, HS ;

Wang, TH ;

Caudle, MR ;

Torry, RJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (06) :1539-1544

← 1 2 3 4 5 6 7 8 9 →